John Truitt, MD
Radiation Oncology · Roswell, NMNPI 1295761898
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 27.1% of the total. Reporting peaked in 2021 at $112 and has fallen 63.1% since, to $41 in 2024. That places this record below the midpoint for radiation oncology clinicians in NM, where the typical reported total is $531.
Across 13 payments — averaging $23.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$84
- Novartis$51
- Boston Scientific$24
- Sanofi$24
- Lilly USA, LLC$24
- Johnson & Johnson$23
- plus $79 from 5 others
What the payments were for
- Food & beverage$310100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 2 | $84 |
| Novartis | 2 | $51 |
| Boston Scientific | 1 | $24 |
| Sanofi | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Johnson & Johnson | 1 | $23 |
| Amgen | 1 | $19 |
| Bayer | 1 | $17 |
| Seagen Inc. | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
How this compares
$310 in reported general payments places this provider in the 35th percentile of 24 radiation oncology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 43 | $271 |
| Anastrozole | 12 | $124 |
| Omeprazole | 22 | $91 |
| Tamsulosin Hcl | 12 | $86 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Roswell
- Gregg FranklinAlbuquerque$75K
- Bryan GossSanta Fe$6K
- Anna Maria de CostaSanta Fe$1K
- Mary BucciAlbuquerque$1K
- Patrick BeagenAlbuquerque$1K
- Mary RoseSanta Fe$868
- Thomas SchroederAlbuquerque$811
- Jeremiah JohnsonAlbuquerque$770
- David LeeAlbuquerque$674
- Peter BernatAlamogordo$669
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.